BioCentury
ARTICLE | Top Story

ImClone raises $500M

May 4, 2004 7:00 AM UTC

Cancer play IMCL raised $500 million in a bumped-up private placement of convertible notes. The notes bear 1.375% interest, mature in 2024 and convert into IMCL stock at $94.69 per share, a premium of...